Monoclonal IgM Antibodies Targeting Candida albicans Hyr1 Provide Cross-Kingdom Protection Against Gram-Negative Bacteria

Recent years have seen an unprecedented rise in the incidence of multidrug-resistant (MDR) Gram-negative bacteria (GNBs) such as Acinetobacter and Klebsiella species. In view of the shortage of novel drugs in the pipeline, alternative strategies to prevent, and treat infections by GNBs are urgently...

Descripción completa

Detalles Bibliográficos
Autores principales: Youssef, Eman G., Zhang, Lina, Alkhazraji, Sondus, Gebremariam, Teclegiorgis, Singh, Shakti, Yount, Nannette Y., Yeaman, Michael R., Uppuluri, Priya, Ibrahim, Ashraf S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045048/
https://www.ncbi.nlm.nih.gov/pubmed/32153560
http://dx.doi.org/10.3389/fimmu.2020.00076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045048/
https://www.ncbi.nlm.nih.gov/pubmed/32153560
http://dx.doi.org/10.3389/fimmu.2020.00076

Ejemplares similares